Flare Rate Thresholds for Patient Assessment of Disease Activity States in Gout.


Journal

The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984

Informations de publication

Date de publication:
02 2021
Historique:
accepted: 21 04 2020
pubmed: 3 5 2020
medline: 1 9 2021
entrez: 3 5 2020
Statut: ppublish

Résumé

To determine the relationship between gout flare rate and self-categorization into remission, low disease activity (LDA), and patient acceptable symptom state (PASS). Patients with gout self-categorized as remission, LDA, and PASS, and reported number of flares over the preceding 6 and 12 months. Multinomial logistic regression was used to determine the association between being in each disease state (LDA and PASS were combined) and flare count, and self-reported current flare. A distribution-based approach and extended Youden index identified possible flare count thresholds for each state. Investigators from 17 countries recruited 512 participants. Remission was associated with a median recalled flare count of zero over both 6 and 12 months. Each recalled flare reduced the likelihood of self-perceived remission compared with being in higher disease activity than LDA/PASS, by 52% for 6 months and 23% for 12 months, and the likelihood of self-perceived LDA/PASS by 15% and 5% for 6 and 12 months, respectively. A threshold of 0 flares in preceding 6 and 12 months was associated with correct classification of self-perceived remission in 58% and 56% of cases, respectively. Flares are significantly associated with perceptions of disease activity in gout, and no flares over the prior 6 or 12 months is necessary for most people to self-categorize as being in remission. However, recalled flare counts alone do not correctly classify all patients into self-categorized disease activity states, suggesting that other factors may also contribute to self-perceived gout disease activity.

Identifiants

pubmed: 32358154
pii: jrheum.191242
doi: 10.3899/jrheum.191242
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

293-298

Subventions

Organisme : NIAMS NIH HHS
ID : P30 AR072571
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 by the Journal of Rheumatology.

Auteurs

William Taylor (W)

W. Taylor, MBChB, PhD, FRACP, FAFRM, University of Otago, Wellington, New Zealand.

Nicola Dalbeth (N)

N. Dalbeth, MBChB, MD, FRACP, P. Tan, University of Auckland, Auckland, New Zealand.

Kenneth G Saag (KG)

K.G. Saag, MD, MSc, E.J. Rahn, PhD, A.S. Mudano, MPH, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Jasvinder A Singh (JA)

J.A. Singh, MD, MPH, A.L. Gaffo, MD, MSPH, University of Alabama at Birmingham, and Birmingham VA Medical Center, Birmingham, Alabama, USA.

Elizabeth J Rahn (EJ)

K.G. Saag, MD, MSc, E.J. Rahn, PhD, A.S. Mudano, MPH, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Amy S Mudano (AS)

K.G. Saag, MD, MSc, E.J. Rahn, PhD, A.S. Mudano, MPH, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Yi-Hsing Chen (YH)

Y.H. Chen, MD, PhD, C.T. Lin, MD, Taichung Veterans General Hospital, Taichung, Taiwan.

Ching-Tsai Lin (CT)

Y.H. Chen, MD, PhD, C.T. Lin, MD, Taichung Veterans General Hospital, Taichung, Taiwan.

Paul Tan (P)

N. Dalbeth, MBChB, MD, FRACP, P. Tan, University of Auckland, Auckland, New Zealand.

Worawit Louthreno (W)

W. Louthreno, MD, Chiang Mai University, Chiang Mai, Thailand.

Janitzia Vazquez-Mellado (J)

J. Vazquez-Mellado, MD, PhD, H. Hernández-Llinas, MD, Hospital General de Mexico, Mexico City, Mexico.

Hansel Hernández-Llinas (H)

J. Vazquez-Mellado, MD, PhD, H. Hernández-Llinas, MD, Hospital General de Mexico, Mexico City, Mexico.

Tuhina Neogi (T)

T. Neogi, MD, PhD, FRCPC, A.B. Vargas-Santos, MD, Boston University School of Medicine, Boston, Massachusetts, USA.

Ana B Vargas-Santos (AB)

T. Neogi, MD, PhD, FRCPC, A.B. Vargas-Santos, MD, Boston University School of Medicine, Boston, Massachusetts, USA.

Geraldo Castelar-Pinheiro (G)

G. Castelar-Pinheiro, MD, PhD, R.B. Chaves-Amorim, MD, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.

Rodrigo B Chaves-Amorim (RB)

G. Castelar-Pinheiro, MD, PhD, R.B. Chaves-Amorim, MD, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.

Tillman Uhlig (T)

T. Uhlig, MD, H.B. Hammer, MD, PhD, Diakonhjemmet Hospital, Oslo, Norway.

Hilde B Hammer (HB)

T. Uhlig, MD, H.B. Hammer, MD, PhD, Diakonhjemmet Hospital, Oslo, Norway.

Maxim Eliseev (M)

M. Eliseev, PhD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia.

Fernando Perez-Ruiz (F)

F. Perez-Ruiz, MD, PhD, Servicio de Reumatologia, Baracaldo, Spain.

Lorenzo Cavagna (L)

L. Cavagna, MD, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.

Geraldine M McCarthy (GM)

G.M. McCarthy, MD, FRCPI, Mater Misericordiae University Hospital, Dublin, Ireland.

Lisa K Stamp (LK)

L.K. Stamp, MBChB, FRACP, PhD, University of Otago-Christchurch, Christchurch, New Zealand.

Martijin Gerritsen (M)

M. Gerritsen, MD, PhD, Westfries Gasthuis, Hoorn, the Netherlands.

Viktoria Fana (V)

V. Fana, MD, Copenhagen Center for Artritis Reserch, Righospitalet Glostrup, Denmark.

Francisca Sivera (F)

F. Sivera, MD, PhD, Hospital General Universitario Elda, Elda, Spain.

Angelo L Gaffo (AL)

J.A. Singh, MD, MPH, A.L. Gaffo, MD, MSPH, University of Alabama at Birmingham, and Birmingham VA Medical Center, Birmingham, Alabama, USA; agaffo@uabmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH